Von Willebrand Factor and ADAMTS13: Too Much or Too Little of a Good Thing?
- PMID: 27879275
- PMCID: PMC5127281
- DOI: 10.1161/ATVBAHA.116.308531
Von Willebrand Factor and ADAMTS13: Too Much or Too Little of a Good Thing?
Keywords: ADAM proteins; Editorial; Von Willebrand factor; cause of death; disintegrin; thrombospondins.
Comment on
-
Von Willebrand Factor, ADAMTS13, and the Risk of Mortality: The Rotterdam Study.Arterioscler Thromb Vasc Biol. 2016 Dec;36(12):2446-2451. doi: 10.1161/ATVBAHA.116.308225. Epub 2016 Oct 13. Arterioscler Thromb Vasc Biol. 2016. PMID: 27737864
References
-
- Levy GG, Nichols WC, Lian EC, Foroud T, McClintick JN, McGee BM, Yang AY, Siemieniak DR, Stark KR, Gruppo R, Sarode R, Shurin SB, Chandrasekaran V, Stabler SP, Sabio H, Bouhassira EE, Upshaw JD, Jr, Ginsburg D, Tsai HM. Mutations in a member of the adamts gene family cause thrombotic thrombocytopenic purpura. Nature. 2001;413:488–494. - PubMed
-
- Sonneveld MA, de Maat MP, Leebeek FW. Von willebrand factor and adamts13 in arterial thrombosis: A systematic review and meta-analysis. Blood Rev. 2014;28:167–178. - PubMed
-
- Bongers TN, de Bruijne EL, Dippel DW, de Jong AJ, Deckers JW, Poldermans D, de Maat MP, Leebeek FW. Lower levels of adamts13 are associated with cardiovascular disease in young patients. Atherosclerosis. 2009;207:250–254. - PubMed
-
- Sonneveld MA, Kavousi M, Ikram MA, Hofman A, Rueda Ochoa OL, Turecek PL, Franco OH, Leebeek FW, de Maat MP. Low adamts-13 activity and the risk of coronary heart disease - a prospective cohort study: The rotterdam study. J Thromb Haemost. 2016 - PubMed
-
- Sonneveld MA, de Maat MP, Portegies ML, Kavousi M, Hofman A, Turecek PL, Rottensteiner H, Scheiflinger F, Koudstaal PJ, Ikram MA, Leebeek FW. Low adamts13 activity is associated with an increased risk of ischemic stroke. Blood. 2015;126:2739–2746. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources